Exact Mass: 501.2151

Exact Mass Matches: 501.2151

Found 91 metabolites which its exact mass value is equals to given mass value 501.2151, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

D-Glucosaminide

D-Glucosaminide

C18H35N3O13 (501.217)


   

D-Glucosaminide

(2R,3R,4R,5S,6R)-3-amino-5-{[(3R,4R,6R)-3-amino-5-{[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-(hydroxymethyl)oxane-2,4-diol

C18H35N3O13 (501.217)


D-Glucosaminide is an intermediate in the Human Aminosugars metabolism, the substrate of the enzyme di-N-acetyl-chitobiase [EC:3.2.1.-], from the Glycosidases class (i.e.: enzymes hydrolyzing O- and S-glycosyl compounds). (KEGG) [HMDB] D-Glucosaminide is an intermediate in the Human Aminosugars metabolism, the substrate of the enzyme di-N-acetyl-chitobiase [EC:3.2.1.-], from the Glycosidases class (i.e.: enzymes hydrolyzing O- and S-glycosyl compounds). (KEGG).

   

Chitotriose

(2R,3R,4S,5R)-2-amino-4-{[(2S,3R,4R,5S,6R)-3-amino-5-{[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,5,6-trihydroxyhexanal

C18H35N3O13 (501.217)


Chitotriose is an enzyme inhibitor. Chitotriose caused a strong reduction in the inhibitory effects of human lysozymes. (PMID: 2911608). Of several sugars and amino sugars tested, chitotriose caused greater than 90\\% inhibition of adherence to S-HA(Saliva supernatant protein). Chitotriose is an enzyme inhibitor. Chitotriose caused a strong reduction in the inhibitory effects of human lysozymes. (PMID: 2911608)

   

Dihidrozeatin riboside-O-glucoside

Dihidrozeatin riboside-O-glucoside

C20H31N5O10 (501.2071)


   

alpha-L-Rhap-(1?3)-beta-D-GalpNAc-(1?1)-ribitol|OS I

alpha-L-Rhap-(1?3)-beta-D-GalpNAc-(1?1)-ribitol|OS I

C19H35NO14 (501.2057)


   

Ala Glu Pro Trp

(4S)-4-[(2S)-2-aminopropanamido]-5-[(2S)-2-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C24H31N5O7 (501.2223)


   

Ala Glu Trp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carboxybutanamido]-3-(1H-indol-3-yl)propanoyl]pyrrolidine-2-carboxylic acid

C24H31N5O7 (501.2223)


   

Ala Pro Glu Trp

(4S)-4-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-4-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C24H31N5O7 (501.2223)


   

Ala Pro Trp Glu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-(1H-indol-3-yl)propanamido]pentanedioic acid

C24H31N5O7 (501.2223)


   

Ala Trp Glu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-indol-3-yl)propanamido]-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid

C24H31N5O7 (501.2223)


   

Ala Trp Pro Glu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}pentanedioic acid

C24H31N5O7 (501.2223)


   

Cys His Arg Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanoic acid

C18H31N9O6S (501.2118)


   

Cys His Ser Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanoic acid

C18H31N9O6S (501.2118)


   

Cys Arg His Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanoic acid

C18H31N9O6S (501.2118)


   

Cys Arg Ser His

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H31N9O6S (501.2118)


   

Cys Ser His Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanoic acid

C18H31N9O6S (501.2118)


   

Cys Ser Arg His

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H31N9O6S (501.2118)


   

Asp Asp Pro Arg

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C19H31N7O9 (501.2183)


   

Asp Asp Arg Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C19H31N7O9 (501.2183)


   

Asp Pro Asp Arg

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}-3-carboxypropanamido]-5-carbamimidamidopentanoic acid

C19H31N7O9 (501.2183)


   

Asp Pro Arg Asp

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]butanedioic acid

C19H31N7O9 (501.2183)


   

Asp Arg Asp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-5-carbamimidamidopentanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C19H31N7O9 (501.2183)


   

Asp Arg Pro Asp

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C19H31N7O9 (501.2183)


   

Glu Ala Pro Trp

(4S)-4-amino-4-{[(2S)-1-[(2S)-2-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}pyrrolidin-1-yl]-1-oxopropan-2-yl]carbamoyl}butanoic acid

C24H31N5O7 (501.2223)


   

Glu Ala Trp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]propanamido]-3-(1H-indol-3-yl)propanoyl]pyrrolidine-2-carboxylic acid

C24H31N5O7 (501.2223)


   

Glu Glu Pro Gln

(4S)-4-[(2S)-2-amino-4-carboxybutanamido]-5-[(2S)-2-{[(1S)-3-carbamoyl-1-carboxypropyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C20H31N5O10 (501.2071)


   

Glu Glu Gln Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-4-carboxybutanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C20H31N5O10 (501.2071)


   

Glu Pro Ala Trp

(4S)-4-amino-5-[(2S)-2-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}ethyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C24H31N5O7 (501.2223)


   

Glu Pro Glu Gln

(4S)-4-{[(2S)-1-[(2S)-2-amino-4-carboxybutanoyl]pyrrolidin-2-yl]formamido}-4-{[(1S)-3-carbamoyl-1-carboxypropyl]carbamoyl}butanoic acid

C20H31N5O10 (501.2071)


   

Glu Pro Gln Glu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-carboxybutanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]pentanedioic acid

C20H31N5O10 (501.2071)


   

Glu Pro Trp Ala

(4S)-4-amino-5-[(2S)-2-{[(1S)-1-{[(1S)-1-carboxyethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C24H31N5O7 (501.2223)


   

Glu Gln Glu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-4-carbamoylbutanamido]-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid

C20H31N5O10 (501.2071)


   

Glu Gln Pro Glu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}pentanedioic acid

C20H31N5O10 (501.2071)


   

Glu Trp Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-(1H-indol-3-yl)propanamido]propanoyl]pyrrolidine-2-carboxylic acid

C24H31N5O7 (501.2223)


   

Glu Trp Pro Ala

(4S)-4-amino-4-{[(2S)-1-[(2S)-2-{[(1S)-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]carbamoyl}butanoic acid

C24H31N5O7 (501.2223)


   

His Cys Arg Ser

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanoic acid

C18H31N9O6S (501.2118)


   

His Cys Ser Arg

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanoic acid

C18H31N9O6S (501.2118)


   

His Arg Cys Ser

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C18H31N9O6S (501.2118)


   

His Arg Ser Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C18H31N9O6S (501.2118)


   

His Ser Cys Arg

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanoic acid

C18H31N9O6S (501.2118)


   

His Ser Arg Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanoic acid

C18H31N9O6S (501.2118)


   

Pro Ala Glu Trp

(4S)-4-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-4-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanoic acid

C24H31N5O7 (501.2223)


   

Pro Ala Trp Glu

(2S)-2-[(2S)-3-(1H-indol-3-yl)-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]pentanedioic acid

C24H31N5O7 (501.2223)


   

Pro Asp Asp Arg

(2S)-5-carbamimidamido-2-[(2S)-3-carboxy-2-[(2S)-3-carboxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]pentanoic acid

C19H31N7O9 (501.2183)


   

Pro Asp Arg Asp

(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-3-carboxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]pentanamido]butanedioic acid

C19H31N7O9 (501.2183)


   

Pro Glu Ala Trp

(4S)-4-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}ethyl]carbamoyl}-4-[(2S)-pyrrolidin-2-ylformamido]butanoic acid

C24H31N5O7 (501.2223)


   

Pro Glu Glu Gln

(4S)-4-{[(1S)-1-{[(1S)-3-carbamoyl-1-carboxypropyl]carbamoyl}-3-carboxypropyl]carbamoyl}-4-[(2S)-pyrrolidin-2-ylformamido]butanoic acid

C20H31N5O10 (501.2071)


   

Pro Glu Gln Glu

(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-4-carboxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]butanamido]pentanedioic acid

C20H31N5O10 (501.2071)


   

Pro Glu Trp Ala

(4S)-4-{[(1S)-1-{[(1S)-1-carboxyethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}-4-[(2S)-pyrrolidin-2-ylformamido]butanoic acid

C24H31N5O7 (501.2223)


   

Pro Gln Glu Glu

(2S)-2-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-4-carboxybutanamido]pentanedioic acid

C20H31N5O10 (501.2071)


   

Pro Arg Asp Asp

(2S)-2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]-3-carboxypropanamido]butanedioic acid

C19H31N7O9 (501.2183)


   

Pro Trp Ala Glu

(2S)-2-[(2S)-2-[(2S)-3-(1H-indol-3-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]pentanedioic acid

C24H31N5O7 (501.2223)


   

Pro Trp Glu Ala

(4S)-4-{[(1S)-1-carboxyethyl]carbamoyl}-4-[(2S)-3-(1H-indol-3-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanoic acid

C24H31N5O7 (501.2223)


   

Gln Glu Glu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-carboxybutanamido]-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid

C20H31N5O10 (501.2071)


   

Gln Glu Pro Glu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-carboxybutanoyl]pyrrolidin-2-yl]formamido}pentanedioic acid

C20H31N5O10 (501.2071)


   

Gln Pro Glu Glu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-4-carboxybutanamido]pentanedioic acid

C20H31N5O10 (501.2071)


   

Arg Cys His Ser

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanoic acid

C18H31N9O6S (501.2118)


   

Arg Cys Ser His

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H31N9O6S (501.2118)


   

Arg Asp Asp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-carboxypropanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C19H31N7O9 (501.2183)


   

Arg Asp Pro Asp

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C19H31N7O9 (501.2183)


   

Arg His Cys Ser

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C18H31N9O6S (501.2118)


   

Arg His Ser Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C18H31N9O6S (501.2118)


   

Arg Pro Asp Asp

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-carboxypropanamido]butanedioic acid

C19H31N7O9 (501.2183)


   

Arg Ser Cys His

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H31N9O6S (501.2118)


   

Arg Ser His Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C18H31N9O6S (501.2118)


   

Ser Cys His Arg

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanoic acid

C18H31N9O6S (501.2118)


   

Ser Cys Arg His

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H31N9O6S (501.2118)


   

Ser His Cys Arg

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanoic acid

C18H31N9O6S (501.2118)


   

Ser His Arg Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanoic acid

C18H31N9O6S (501.2118)


   

Ser Arg Cys His

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H31N9O6S (501.2118)


   

Ser Arg His Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C18H31N9O6S (501.2118)


   

Trp Ala Glu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]propanamido]-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid

C24H31N5O7 (501.2223)


   

Trp Ala Pro Glu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]propanoyl]pyrrolidin-2-yl]formamido}pentanedioic acid

C24H31N5O7 (501.2223)


   

Trp Glu Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-carboxybutanamido]propanoyl]pyrrolidine-2-carboxylic acid

C24H31N5O7 (501.2223)


   

Trp Glu Pro Ala

(4S)-4-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-5-[(2S)-2-{[(1S)-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C24H31N5O7 (501.2223)


   

Trp Pro Ala Glu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}propanamido]pentanedioic acid

C24H31N5O7 (501.2223)


   

Trp Pro Glu Ala

(4S)-4-{[(2S)-1-[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}-4-{[(1S)-1-carboxyethyl]carbamoyl}butanoic acid

C24H31N5O7 (501.2223)


   

Chitotriose

O-2-amino-2-Deoxy-beta-delta-glucopyranosyl-(1->4)-O-2-amino-2-deoxy-beta-delta-glucopyranosyl-(1->4)-2-amino-2-deoxy-delta-glucose

C18H35N3O13 (501.217)


An amino trisaccharide comprising of three 2-amino-2-deoxy-D-glucopyranose units joined by beta-(1->4) linkages.

   

2-N,2-N,7-N,7-N-tetraphenyl-9H-carbazole-2,7-diamine

2-N,2-N,7-N,7-N-tetraphenyl-9H-carbazole-2,7-diamine

C36H27N3 (501.2205)


   

DOTA-​NHS-​ester

DOTA-​NHS-​ester

C20H31N5O10 (501.2071)


   
   

N3,N3,N6,N6-tetraphenyl-9H-carbazole-3,6-diamine

N3,N3,N6,N6-tetraphenyl-9H-carbazole-3,6-diamine

C36H27N3 (501.2205)


   

FMoc-L-4-(OtButylcarboxyMethyl)phe-OH

FMoc-L-4-(OtButylcarboxyMethyl)phe-OH

C30H31NO6 (501.2151)


   

2-amino-2-deoxy-beta-D-glucopyranosyl-(1->4)-2-amino-2-deoxy-beta-D-glucopyranosyl-(1->4)-2-amino-2-deoxy-D-glucopyranose

2-amino-2-deoxy-beta-D-glucopyranosyl-(1->4)-2-amino-2-deoxy-beta-D-glucopyranosyl-(1->4)-2-amino-2-deoxy-D-glucopyranose

C18H35N3O13 (501.217)


   
   

(S,R)-GSK321

(S,R)-GSK321

C28H28FN5O3 (501.2176)


(S,R)-GSK321 is a potent, selective mutant IDH1 inhibitor with IC50 values of 2.9, 3.8, 4.6 and 46 nM for R132G, R132C, R132H and WT IDH1, respectively, and >100-fold selectivity over IDH2. (S,R)-GSK321 induces decrease in intracellular 2-HG, abrogation of the myeloid differentiation block and induction of granulocytic differentiation at the level of leukemic blasts and more immature stem-like cells. (S,R)-GSK321can be used for research of acute myeloid leukemia (AML) and other cancers[1].

   

GSK321

GSK321

C28H28FN5O3 (501.2176)


GSK321 is a potent inhibitor of mutant isocitrate dehydrogenase 1 (IDH1) enzymes. GSK321 has high inhibitory and selectivity for mutant IDH1 enzymes. GSK321 can be used for the research of acute myeloid leukemia[1][2].

   

(2s,3r,4r,5s,6r)-2-{[(2s)-4-({9-[(2s,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl}amino)butan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4r,5s,6r)-2-{[(2s)-4-({9-[(2s,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl}amino)butan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C20H31N5O10 (501.2071)


   

(2r,3r,4r,6r)-3-amino-5-{[(2s,3r,4r,6r)-3-amino-5-{[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-(hydroxymethyl)oxane-2,4-diol

(2r,3r,4r,6r)-3-amino-5-{[(2s,3r,4r,6r)-3-amino-5-{[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-(hydroxymethyl)oxane-2,4-diol

C18H35N3O13 (501.217)


   

3,7-dibenzoyl-5-(3-methylbut-2-en-1-yl)-10h-phenazine-1-carboximidic acid

3,7-dibenzoyl-5-(3-methylbut-2-en-1-yl)-10h-phenazine-1-carboximidic acid

C32H27N3O3 (501.2052)